Influence of Breakfast Consumption on Chlorogenic Acid Metabolism in Humans

NCT ID: NCT01523028

Last Updated: 2013-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Data and knowledge gathered on bioavailability of coffee phenolics is becoming more and more important, hence underlying the importance of better understanding the fate of these potential health promoting antioxidants. However, some analytical barriers as well as some key aspects of metabolism still remain to be fully elucidated to get the full picture of coffee metabolism and bioavailability. One aspect addressed in the present study is the impact of food matrix in modulating absorption, plasma appearance and urinary excretion of coffee bioactives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coffee, bread and honey

200 mL coffee + 2 bread rolls + honey

Group Type EXPERIMENTAL

Soluble Coffee

Intervention Type OTHER

Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:

* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter

Coffee, bread and peanut butter

200 mL coffee + 1 bread roll + peanut butter

Group Type EXPERIMENTAL

Soluble Coffee

Intervention Type OTHER

Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:

* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter

200 mL black coffee

Group Type EXPERIMENTAL

Soluble Coffee

Intervention Type OTHER

Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:

* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Soluble Coffee

Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:

* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy men and women
* Aged 20-44 years
* Caucasian origin
* Body mass index (BMI) 19-25 kg/m2
* Used to drinking coffee (similar to study coffee) on a daily basis
* Being able to tolerate a 48-hour coffee abstinence
* Normal oral glucose tolerance test
* Having signed the informed consent form

Exclusion Criteria

* Taking medication or dietary supplements
* Smoking
* Performing a competitive sport
* Having metabolic disorders
* Long gut transit time (\>24 h)
* Blood donor
* Irregularity in menstrual cycle (for women)
* Pregnancy (for women)
* Subject who cannot be expected to comply with the study procedures.
* Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.
Minimum Eligible Age

20 Years

Maximum Eligible Age

44 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Kaiserslautern

Kaiserslautern, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11.12.NRC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Interindividual Variation in Response to Green Coffee
NCT06204445 ACTIVE_NOT_RECRUITING NA
Coffee and In-vivo Oxidative Stress
NCT00868205 COMPLETED PHASE2